Laserfiche WebLink
and triphenyltin compounds is shown in Figure 1. <br />The tendency of an organotin compound to be concentrated by an organism <br />depends on its partition behavior between lipid and aqueous phases. In <br />general, compounds highly soluble in octanol and only slightly soluble in <br />water have high Kow values. Kow values of organotins increase with number and <br />molecular weight of organic groups attached to the tin atom, with significant <br />bioaccumulation potential for organotins with R groups of butyl and larger <br />(Thompson et al. 1985). Kow values for tributyltins in seawater vary from <br />5,500 to 7,000, but can be significantly modified by salinity and speciation <br />products (Laughlin et al. 1986b). Thus, organotins would be expected to <br />accumulate in lipid-rich surface microlayers of natural waters (Cardwell and <br />Sheldon 1986) and in biota (as discussed later). However, the ability of <br />microorganisms, algae, and higher organisms to reduce various organotins into <br />less toxic metabolites that can be rapidly excreted seems to preclude food <br />chain biomagnification and to lessen the potential hazards to natural <br />resources from consumption of organisms with elevated organotin residues <br />(Table 1; Cardwell and Sheldon 1986). <br />Most authorities now agree on five points: (1) information concerning the <br />mechanism of the toxic action of organotin compounds is inadequate; (2) <br />results of all studies with various organotins for possible carcinogenicity <br />are negative; (3) triorganotin compounds are the most toxic group of <br />organotins; (4) large inter- and intraspecies differences exist in resistance <br />to organotin compounds; and (5) organotins can alter enzyme activity levels in <br />many organs and tissues including brain, liver, and kidney (Piver 1973; Duncan <br />1980; WHO 1980; Davies and Smith 1982; Maguire et al. 1982; Arakawa and Wada <br />1984; Dwivedi et al. 1985b; Blunden and Chapman 1986). <br />The monoorganotin compounds, RSnX 1 have a generally low toxicity and do <br />not seem to have any important biological action in mammals (Duncan 1980; <br />Davies and Smith 1982; Krigman and Silverman 1984; Blunden and Chapman 1986). <br />Dialkylorganotins, R SnX2, are associated with hepatotoxicity (ethyl, <br />propyl, butyl, and pentylt?ns), immunotoxic effects to T-cells (butyl and <br />octyltins), and skin and eye irritation (methyl, ethyl, propyl, butyl, and <br />octyltins; Watanabe 1980; Krigman and Silverman 1984). The diorganotins <br />combine with coenzymes or enzymes possessing dithiol groups and exert their <br />toxic action by inhibiting alpha-keto acid oxidation and blocking <br />mitochondrial respiration (Duncan 1980; WHO 1980; Davies and Smith 1982). <br />Resistance to diorganotin toxicity varies widely among species. For example, <br />dibutyltins and dioutyltins--unlike other organotins tested--were toxic to rat <br />thymocytes, but did not induce similar effects on lymphoid atrophy in mice, <br />guinea pigs, or Japanese quail (Seinen et al. 1977b). Selected dibutyltins <br />are effective as antihelminthics and are used to kill parasitic worms in <br />chickens and turkeys without harm to host birds (Davies and Smith 1982). <br />8